Literature DB >> 12366826

Chaperones of the type III secretion pathway: jacks of all trades.

Anne-Laure Page1, Claude Parsot.   

Abstract

The type III secretion (TTS) pathway is used by many Gram-negative bacteria to inject virulence proteins into cells of their host. The activity of the TTS apparatus is controlled by external signals and, in certain conditions, production and secretion are not coupled. Storage of some proteins before secretion involves their association with specific chaperones. Three classes of TTS chaperones have been distinguished according to whether they associate with: (i) one; (ii) several effector proteins; or (iii) the two translocators that allow passage of effectors across the membrane of eukaryotic cells. These chaperones are required for stabilization of their substrate(s) and prevention of their premature interactions with other partners during storage. They also play a role in secretion of their substrate(s). Some chaperones are also involved in transcriptional regulation of certain genes in response to the activity of secretion. The flagellar export apparatus is closely related to the TTS apparatus and some proteins of the flagellar export system have also been proposed to be chaperones that prevent premature interactions between the flagellum subunits.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12366826     DOI: 10.1046/j.1365-2958.2002.03138.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  52 in total

1.  Structure of Spa15, a type III secretion chaperone from Shigella flexneri with broad specificity.

Authors:  André van Eerde; Cyril Hamiaux; Javier Pérez; Claude Parsot; Bauke W Dijkstra
Journal:  EMBO Rep       Date:  2004-04-16       Impact factor: 8.807

2.  Translocated intimin receptor and its chaperone interact with ATPase of the type III secretion apparatus of enteropathogenic Escherichia coli.

Authors:  Annick Gauthier; B Brett Finlay
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490

3.  Diverse AvrPtoB homologs from several Pseudomonas syringae pathovars elicit Pto-dependent resistance and have similar virulence activities.

Authors:  Nai-Chun Lin; Robert B Abramovitch; Young Jin Kim; Gregory B Martin
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

4.  Mutations in the Yersinia pseudotuberculosis type III secretion system needle protein, YscF, that specifically abrogate effector translocation into host cells.

Authors:  Alison J Davis; Joan Mecsas
Journal:  J Bacteriol       Date:  2006-10-27       Impact factor: 3.490

Review 5.  Candida albicans cell wall proteins.

Authors:  W LaJean Chaffin
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

Review 6.  Biological diversity of prokaryotic type IV secretion systems.

Authors:  Cristina E Alvarez-Martinez; Peter J Christie
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

7.  Chlamydia trachomatis Slc1 is a type III secretion chaperone that enhances the translocation of its invasion effector substrate TARP.

Authors:  Amanda J Brinkworth; Denise S Malcolm; António T Pedrosa; Katarzyna Roguska; Sevanna Shahbazian; James E Graham; Richard D Hayward; Rey A Carabeo
Journal:  Mol Microbiol       Date:  2011-09-02       Impact factor: 3.501

Review 8.  Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.

Authors:  Gunnar N Schroeder; Hubert Hilbi
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

9.  Recognition of the Agrobacterium tumefaciens VirE2 translocation signal by the VirB/D4 transport system does not require VirE1.

Authors:  Annette C Vergunst; Miranda C M van Lier; Amke den Dulk-Ras; Paul J J Hooykaas
Journal:  Plant Physiol       Date:  2003-10-09       Impact factor: 8.340

10.  Substrate-activated conformational switch on chaperones encodes a targeting signal in type III secretion.

Authors:  Li Chen; Xuanjun Ai; Athina G Portaliou; Conceicao A S A Minetti; David P Remeta; Anastassios Economou; Charalampos G Kalodimos
Journal:  Cell Rep       Date:  2013-03-21       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.